Compile Data Set for Download or QSAR
Report error Found 22 Enz. Inhib. hit(s) with all data for entry = 11632
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635467(US11814386, Compound 1-b)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635487(US11814386, Compound 20-b | N-((3aS,6aR)- 2- cyano...)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635486(US11814386, Compound 20-a | N-((3aR,6aS)- 2- cyano...)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635485(US11814386, Compound 13-b | N- ((1R,4S,5R)- 2-cyan...)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635484(US11814386, Compound 13-a | N- ((1S,4R,5S)- 2-cyan...)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635478(US11814386, Compound 7-a | N- ((1S,2S,4R)- 7-cyano...)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635476(US11814386, Compound 6-a)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635474(US11814386, Compound 5-a | (S)-N-(5- cyano-5- azas...)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635471(US11814386, Compound 3-b)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635468(US11814386, Compound 2-a | N- ((1S,4S,7S)-2- cyano...)
Affinity DataIC50: 100nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635473(US11814386, Compound 4-b | (1R,4R)-5-(5- (2- pheno...)
Affinity DataIC50: 550nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635475(US11814386, Compound 5-b | (R)-N-(5- cyano-5- azas...)
Affinity DataIC50: 550nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635472(US11814386, Compound 4-a | (1S,4S)-5-(5- (2- pheno...)
Affinity DataIC50: 550nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635477(US11814386, Compound 6-b)
Affinity DataIC50: 550nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635479(US11814386, Compound 7-b | N- ((1R,2R,4S)- 7-cyano...)
Affinity DataIC50: 550nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635480(US11814386, Compound 8-a | N- ((1R,4R,5S)- 2-cyano...)
Affinity DataIC50: 550nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635481(US11814386, Compound 8-b | N- ((1S,4S,5R)- 2-cyano...)
Affinity DataIC50: 550nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635470(US11814386, Compound 3-a)
Affinity DataIC50: 550nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635466(US11814386, Compound 1-a)
Affinity DataIC50: 550nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635482(US11814386, Compound 9-a | N-[(7S)-5- cyano-2-oxa-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635483(US11814386, Compound 9-b | N-[(7R)-5- cyano-2-oxa-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Forma Therapeutics

US Patent
LigandPNGBDBM635469(US11814386, Compound 2-b | N- ((1R,4R,7R)- 2-cyano...)
Affinity DataIC50: 1.00E+3nMAssay Description:The assay was performed in a final volume of 9 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (IM Tris-HCl, pH 8.0 solution; Corning 46-0...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent